Literature DB >> 19023270

Mesenchymal stem cells as trojan horses for GDNF delivery in ALS.

Brian K Kaspar1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19023270     DOI： 10.1038/mt.2008.216

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  6 in total

Review 1.  Neuroprotection for amyotrophic lateral sclerosis: role of stem cells, growth factors, and gene therapy.

Authors:  Rachna S Pandya; Lilly L J Mao; Edward W Zhou; Robert Bowser; Zhenglun Zhu; Yongjin Zhu; Xin Wang
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2012-03

Review 2.  Concise review: adult mesenchymal stem cells, adult neural crest stem cells, and therapy of neurological pathologies: a state of play.

Authors:  Virginie Neirinckx; Cécile Coste; Bernard Rogister; Sabine Wislet-Gendebien
Journal:  Stem Cells Transl Med       Date:  2013-03-13       Impact factor: 6.940

3.  Neural stem cells as a therapeutic approach for amyotrophic lateral sclerosis.

Authors:  Laura Ferraiuolo; Ashley Frakes; Brian K Kaspar
Journal:  Mol Ther       Date:  2013-03       Impact factor: 11.454

4.  Human motor neurons generated from neural stem cells delay clinical onset and prolong life in ALS mouse model.

Authors:  Hong J Lee; Kwang S Kim; Jin Ahn; Hye M Bae; Inja Lim; Seung U Kim
Journal:  PLoS One       Date:  2014-05-20       Impact factor: 3.240

5.  Multiple Autologous Bone Marrow-Derived CD271+ Mesenchymal Stem Cell Transplantation Overcomes Drug-Resistant Epilepsy in Children.

Authors:  Olga Milczarek; Danuta Jarocha; Anna Starowicz-Filip; Stanislaw Kwiatkowski; Bogna Badyra; Marcin Majka
Journal:  Stem Cells Transl Med       Date:  2017-12-10       Impact factor: 6.940

Review 6.  Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases.

Authors:  Della Grace Thomas Parambi; Khalid Saad Alharbi; Rajesh Kumar; Seetha Harilal; Gaber El-Saber Batiha; Natália Cruz-Martins; Omnia Magdy; Arafa Musa; Dibya Sundar Panda; Bijo Mathew
Journal:  Mol Neurobiol       Date:  2021-10-15       Impact factor: 5.682
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.